RAMM Pharma Corp.

  • Market Cap: Micro Cap
  • Industry: FMCG
  • ISIN: CA75150G1046
CAD
0.06
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About RAMM Pharma Corp. stock-summary
stock-summary
RAMM Pharma Corp.
FMCG
RAMM Pharma Corp. is a Canada-based company that provides plant-derived cannabinoid pharmaceutical products. The Company is engaged in the field of cannabinoid pharmacology and product formulation for cannabis-derived prescription drugs and registered products. It also operates a pharmaceutical, cosmetic and nutraceutical product development and medical services business. It sells five cannabis-based products in Uruguay under two brands: Epifractan and CannabiPiel. Epifractan treats a variety of medical conditions and pathologies. CannabiPiel is a cosmetic cream for the treatment of joint pain and inflammation, as well as a variety of skin disorders.
Company Coordinates stock-summary
Company Details
Scotia Plaza, 40 King street west, Suite 2100 TORONTO ON : M5H3C2
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Apr 2025)
Net Profit:
0 Million
stock-summary
Industry

FMCG

stock-summary
Market cap

CAD 1 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.04

stock-summary
Return on Equity

-28.19%

stock-summary
Price to Book

0.10